MEGAN PUTMAN: Open Payments
NPI 1689834079 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 61 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $432 · 2025 $2,028
Food & beverage: $1,809Education: $219
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $380 |
| ABBVIE INC. | 8 | $339 |
| UCB, Inc. | 6 | $254 |
| Galderma Laboratories, L.P. | 3 | $196 |
| SANOFI-AVENTIS U.S. LLC | 2 | $171 |
| GENZYME CORPORATION | 7 | $148 |
| PFIZER INC. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Incyte Corporation | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, NEMLUVIO, CIBINQO, SKYRIZI, Opzelura.
Industry payments across MD — which companies pay providers there.
